Key result
Co-infection of Parvovirus B19 and COVID-19 in a young male precipitated acute myocarditis characterized by fulminant progression and multiple arrhythmias.
Why the study?
Co-infections of cardiotropic viruses are rarely reported, and the mechanisms of viral interactions remain unknown.
Case Report (n=1)
This case highlights the potential for fulminant progression and severe arrhythmias in acute myocarditis precipitated by a rare co-infection of Parvovirus B19 and COVID-19.
Raises caution for co-infection screening in fulminant myocarditis; leaves open synergistic effects of Parvovirus B19 and COVID-19.
Myocarditis can be caused by a variety of infectious and non-infectious illnesses [1]. Although viral infection remains the most commonly identified cause of myocarditis, the role of parvovirus B19 (B19V) from the Erythrovirus genus in the pathogenesis of myocarditis has been identified as a potentially important contributor to myocarditis because of the high prevalence of Parvovirus B 19 (B19V) DNA in hearts of patients with myocarditis [2]. Co-infections of cardiotropic viruses are rarely reported and the mechanisms of viral interactions remain unknown [3]. In this report, we present a case of acute myocarditis in a young male, precipitated by a co-infection of Parvovirus B19 and COVID-19, characterized by fulminant progression and the development of multiple arrhythmias.
No takes yet. Share an insight, caveat, or question.
Khalikh et al. (2023) conducted a case report in acute myocarditis (n=1). Co-infection of Parvovirus B19 and COVID-19 was evaluated on fulminant progression and development of multiple arrhythmias. Co-infection of Parvovirus B19 and COVID-19 in a young male precipitated acute myocarditis characterized by fulminant progression and multiple arrhythmias.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: